Molecular Diagnostics
News on lab-developed tests and emerging diagnostic technologies.
Updated NCCN Guidelines Adjust Ratings for Prostate Cancer Genetic Tests
The newest version ups its endorsement of somatic genomic testing to "recommended" for advanced cancers and shifts its recommendations on early-stage risk assays.
Cepheid Tuberculosis Assay Receives WHO Prequalification
The WHO noted that Cepheid's test is the first test for tuberculosis and antibiotic susceptibility testing that meets the prequalification standards.
Foresight Diagnostics Launches Lymphoma Personalized Treatment Clinical Trial
The trial will study the use of Foresight's Clarity MRD assay in identifying early treatment responders for therapy de-escalation.
VA Offering No-Cost PGx Testing Through End of 2025
The program will be rolled out within Veterans Integrated Service Network 4 facilities, which served more than 300,000 patients last year.
Investigators Urge Additional Screening to Catch Maternal Cancer From Nonreportable NIPT Results
An NIH team detected maternal cancers in nearly half of individuals with unusual or nonreportable findings from cell-free DNA-based fetal aneuploidy tests.